IDiyas

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 9522914 B1

PDFFull Text
Date of Patent:
Dec. 20, 2016

Filed:

Oct. 25, 2012

Azole derivative

Applicant:

Taisho Pharmaceutical Co., Ltd, Toshima-ku, Tokyo, JP;

Inventors:

Mitsukane Yoshinaga, Tokyo, JP;

Takeshi Kuwada, Tokyo, JP;

Naoki Miyakoshi, Tokyo, JP;

Tomoko Ishizaka, Tokyo, JP;

Daisuke Wakasugi, Tokyo, JP;

Shin-ichi Shirokawa, Tokyo, JP;

Nobutaka Hattori, Tokyo, JP;

Youichi Shimazaki, Tokyo, JP;

Assignee:

TAISHO PHARMACEUTICAL CO., LTD, Tokyo, JP;

Attorney:

Sughrue Mion, PLLC

Primary Examiner:

Rebecca Anderson

Assistant Examiner:

Po-Chih Chen

Int. Cl.
CPC ...
C07D 491/107 (2006.01); C07D 471/08 (2006.01); C07D 403/10 (2006.01); C07D 498/08 (2006.01); C07D 233/64 (2006.01); C07D 401/10 (2006.01); C07D 231/12 (2006.01); C07D 233/70 (2006.01); C07D 233/90 (2006.01); C07D 401/04 (2006.01); C07D 403/04 (2006.01); C07D 403/06 (2006.01); C07D 413/10 (2006.01); C07D 249/08 (2006.01); C07D 451/06 (2006.01); C07D 249/10 (2006.01); C07D 249/12 (2006.01); C07D 263/32 (2006.01); C07D 277/20 (2006.01); C07D 277/30 (2006.01); C07D 207/444 (2006.01);
U.S. Cl.
CPC ...
C07D 471/08 (2013.01); C07D 207/444 (2013.01); C07D 231/12 (2013.01); C07D 233/64 (2013.01); C07D 233/70 (2013.01); C07D 233/90 (2013.01); C07D 249/08 (2013.01); C07D 249/10 (2013.01); C07D 249/12 (2013.01); C07D 263/32 (2013.01); C07D 277/20 (2013.01); C07D 277/30 (2013.01); C07D 401/04 (2013.01); C07D 401/10 (2013.01); C07D 403/04 (2013.01); C07D 403/06 (2013.01); C07D 403/10 (2013.01); C07D 413/10 (2013.01); C07D 451/06 (2013.01); C07D 491/107 (2013.01); C07D 498/08 (2013.01);
Abstract

The present invention provides agents for treating or preventing diseases such as mood disorder, anxiety disorder, schizophrenia, Alzheimer's disease, Parkinson's disease, Huntington's chorea, eating disorder, hypertension, gastrointestinal disease, drug addiction, epilepsy, cerebral infarction, cerebral ischemia, cerebral edema, head injury, inflammation, immune-related disease, alopecia, and so forth. Specifically, the invention provides azole derivatives represented by general formula (I), or pharmaceutically acceptable salts thereof that have an antagonistic action against the arginine-vasopressin (AVP) V1b receptor:

Find Patent Forward Citations

Loading…